Cargando…
Methylation of CDX2 gene promoter in the prediction of treatment efficacy in colorectal cancer
The aim of the present study was to examine the diagnosis of methylation of CDX2 gene promoter in colorectal cancer (CRC) and assessed its value in the prediction of treatment efficacy. Sixty patients who were diagnosed as CRCs for the first time, 60 patients with hyperplastic polyps (HPs) and adeno...
Autores principales: | Wang, Yunshuai, Li, Zhaohui, Li, Wenxian, Liu, Shuaifeng, Han, Baowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006183/ https://www.ncbi.nlm.nih.gov/pubmed/29928401 http://dx.doi.org/10.3892/ol.2018.8670 |
Ejemplares similares
-
Methylation of promoter region of CDX2 gene in colorectal cancer
por: Wang, Yunshuai, et al.
Publicado: (2016) -
Conservative treatment of rectovesical fistula after leakage following laparoscopic radical resection of rectal cancer
por: Yan, Shunli, et al.
Publicado: (2020) -
Prognostic value and predictive biomarkers of phenotypes of tumour‐associated macrophages in colorectal cancer
por: Kou, Yu, et al.
Publicado: (2022) -
Relationships Between the Expressions of CDX1 and CDX2 mRNA and Clinicopathologic Features in Colorectal Cancers
por: Kim, Gwang Ha, et al.
Publicado: (2005) -
CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway
por: Graule, Janina, et al.
Publicado: (2018)